AAAAAA

   
Results: 1-10 |
Results: 10
EFFECT OF AGE ON MITOGEN-INDUCED PROTEIN-TYROSINE PHOSPHORYLATION IN HUMAN T-CELL AND ITS SUBSETS - DOWN-REGULATION OF TYROSINE PHOSPHORYLATION OF ZAP-70
Authors: CHAKRAVARTI B CHAKRAVARTI DN DEVECIS J SESHI B ABRAHAM GN
Citation: B. Chakravarti et al., EFFECT OF AGE ON MITOGEN-INDUCED PROTEIN-TYROSINE PHOSPHORYLATION IN HUMAN T-CELL AND ITS SUBSETS - DOWN-REGULATION OF TYROSINE PHOSPHORYLATION OF ZAP-70, Mechanism of ageing and development, 104(1), 1998, pp. 41-58
THE MOAB-V-KAPPA-IIIB CROSS-REACTIVE IDIOTOPE ON A27A (HUMKV325) ENCODED KAPPA-CHAINS MAPS TO FRAMEWORK REGION-3
Authors: POTTER KN LI YC ABRAHAM GN CAPRA JD
Citation: Kn. Potter et al., THE MOAB-V-KAPPA-IIIB CROSS-REACTIVE IDIOTOPE ON A27A (HUMKV325) ENCODED KAPPA-CHAINS MAPS TO FRAMEWORK REGION-3, Scandinavian journal of immunology, 44(4), 1996, pp. 305-313
HUMAN-IGG PRODUCTION IN-VIVO - DETERMINATION OF SYNTHETIC RATE BY NONRADIOACTIVE TRACER INCORPORATION
Authors: THORNTON CA WELLE S GRIGGS RC ABRAHAM GN
Citation: Ca. Thornton et al., HUMAN-IGG PRODUCTION IN-VIVO - DETERMINATION OF SYNTHETIC RATE BY NONRADIOACTIVE TRACER INCORPORATION, The Journal of immunology, 157(2), 1996, pp. 950-955
THE TREATMENT OF OVARIAN-CANCER WITH A GENE MODIFIED CANCER VACCINE -A PHASE-I STUDY
Authors: FREEMAN SM MCCUNE C ROBINSON W ABBOUD CN ABRAHAM GN ANGEL C MARROGI A
Citation: Sm. Freeman et al., THE TREATMENT OF OVARIAN-CANCER WITH A GENE MODIFIED CANCER VACCINE -A PHASE-I STUDY, Human gene therapy, 6(7), 1995, pp. 927-939
GENE-MODIFIED CELLS FOR THE TREATMENT OF CANCER
Authors: WHARTENBY KA ABRAHAM GN CALABRESI PA ABBOUD CN CALABRESI P MARROGI A FREEMAN SM
Citation: Ka. Whartenby et al., GENE-MODIFIED CELLS FOR THE TREATMENT OF CANCER, Pharmacology & therapeutics, 66(1), 1995, pp. 175-190
APOPTOSIS AND INTERLEUKIN-7 GENE-EXPRESSION IN CHRONIC B-LYMPHOCYTIC LEUKEMIA-CELLS
Authors: LONG BW WITTE PL ABRAHAM GN GREGORY SA PLATE JMD
Citation: Bw. Long et al., APOPTOSIS AND INTERLEUKIN-7 GENE-EXPRESSION IN CHRONIC B-LYMPHOCYTIC LEUKEMIA-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(5), 1995, pp. 1416-1420
AN ANTICANCER DRUG DELIVERY APPROACH USING GENE-MODIFIED TUMOR-CELLS
Authors: FREEMAN SM WHARTENBY KA ABBOUD CN MOOLTEN FL KOEPLIN DS ABRAHAM GN
Citation: Sm. Freeman et al., AN ANTICANCER DRUG DELIVERY APPROACH USING GENE-MODIFIED TUMOR-CELLS, Journal of cellular biochemistry, 1993, pp. 249-249
CLINICAL-TRIALS IN GENE-THERAPY
Authors: FREEMAN SM WHARTENBY KA ABRAHAM GN ZWIEBEL JA
Citation: Sm. Freeman et al., CLINICAL-TRIALS IN GENE-THERAPY, Advanced drug delivery reviews, 12(3), 1993, pp. 169-183
THE BYSTANDER EFFECT - TUMOR-REGRESSION WHEN A FRACTION OF THE TUMOR MASS IS GENETICALLY-MODIFIED
Authors: FREEMAN SM ABBOUD CN WHARTENBY KA PACKMAN CH KOEPLIN DS MOOLTEN FL ABRAHAM GN
Citation: Sm. Freeman et al., THE BYSTANDER EFFECT - TUMOR-REGRESSION WHEN A FRACTION OF THE TUMOR MASS IS GENETICALLY-MODIFIED, Cancer research, 53(21), 1993, pp. 5274-5283
ONCOGENE ELEMENTS WITHIN AN ENDOGENOUS RETROVIRUS
Authors: WHARTENBY KA INSEL RA FREEMAN SM KENG P ABRAHAM GN
Citation: Ka. Whartenby et al., ONCOGENE ELEMENTS WITHIN AN ENDOGENOUS RETROVIRUS, Acta virologica, 37(2-3), 1993, pp. 113-122
Risultati: 1-10 |